These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37160349)
1. Association of nicotine replacement therapy product sales with menthol cigarette sales restriction in Massachusetts. Asare S; Xue Z; Bandi P; Westmaas JL; Jemal A; Nargis N Tob Control; 2023 May; ():. PubMed ID: 37160349 [TBL] [Abstract][Full Text] [Related]
2. Do e-cigarette sales reduce the demand for nicotine replacement therapy (NRT) products in the US? Evidence from the retail sales data. Huang J; Wang Y; Duan Z; Kim Y; Emery SL; Chaloupka FJ Prev Med; 2021 Apr; 145():106376. PubMed ID: 33346035 [TBL] [Abstract][Full Text] [Related]
3. Impact of Massachusetts law prohibiting flavored tobacco products sales on cross-border cigarette sales. Ali FRM; King BA; Seaman EL; Vallone D; Schillo B PLoS One; 2022; 17(9):e0274022. PubMed ID: 36099316 [TBL] [Abstract][Full Text] [Related]
4. Changes in retail sales of tobacco products in Ontario after a menthol sales restriction. Brown EM; Gammon DG; Rogers T; Coats EM; Olson LT; Ross A; Engstrom M; Nonnemaker JM Tob Control; 2022 Dec; 31(e2):e134-e139. PubMed ID: 34257151 [TBL] [Abstract][Full Text] [Related]
5. Changes in Smoking Cessation-Related Behaviors Among US Adults During the COVID-19 Pandemic. Bandi P; Asare S; Majmundar A; Xue Z; Han X; Westmaas JL; Nargis N; Jemal A JAMA Netw Open; 2022 Aug; 5(8):e2225149. PubMed ID: 35913738 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Statewide Restrictions on Flavored e-Cigarette Sales in the US From 2014 to 2020. Ali FRM; Vallone D; Seaman EL; Cordova J; Diaz MC; Tynan MA; Trivers KF; King BA JAMA Netw Open; 2022 Feb; 5(2):e2147813. PubMed ID: 35142832 [TBL] [Abstract][Full Text] [Related]
8. Trends in US E-cigarette Sales and Prices by Nicotine Strength, Overall and by Product and Flavor Type, 2017-2022. Ali FRM; Seaman EL; Crane E; Schillo B; King BA Nicotine Tob Res; 2023 Apr; 25(5):1052-1056. PubMed ID: 36580384 [TBL] [Abstract][Full Text] [Related]
9. Nicotine replacement therapy versus control for smoking cessation. Hartmann-Boyce J; Chepkin SC; Ye W; Bullen C; Lancaster T Cochrane Database Syst Rev; 2018 May; 5(5):CD000146. PubMed ID: 29852054 [TBL] [Abstract][Full Text] [Related]
10. Changes in Sales of E-Cigarettes, Cigarettes, and Nicotine Replacement Therapy Products Before, During, and After the EVALI Outbreak. Wang X; Kim Y; Trivers KF; Tynan MA; Shrestha SS; Emery S; Borowiecki M; Hacker K Prev Chronic Dis; 2022 Dec; 19():E86. PubMed ID: 36520998 [TBL] [Abstract][Full Text] [Related]
11. Changes in Sales of Tobacco and Nicotine Replacement Therapy Products Before and During the COVID-19 Pandemic. Sung J; Shrestha SS; Kim Y; Emery S; Wang X Prev Chronic Dis; 2023 Aug; 20():E71. PubMed ID: 37590902 [TBL] [Abstract][Full Text] [Related]
12. Availability and range of tobacco products for sale in Massachusetts pharmacies. Seidenberg AB; Hong W; Liu J; Noel JK; Rees VW Tob Control; 2013 Nov; 22(6):372-5. PubMed ID: 23138526 [TBL] [Abstract][Full Text] [Related]
13. Interventions to reduce harm from continued tobacco use. Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465 [TBL] [Abstract][Full Text] [Related]
17. The impact of two state-level approaches to restricting the sale of flavored tobacco products. Satchell T; Diaz MC; Stephens D; Bertrand A; Schillo BA; Whitsel LP BMC Public Health; 2022 Sep; 22(1):1799. PubMed ID: 36138373 [TBL] [Abstract][Full Text] [Related]
18. Trying is believing: A pilot study of in-vivo nicotine replacement therapy sampling in disadvantaged Black adults who smoke cigarettes. Liu MA; Brett EI; Chavarria J; King AC Drug Alcohol Depend; 2022 Dec; 241():109679. PubMed ID: 36332594 [TBL] [Abstract][Full Text] [Related]